Ian Morrissey, 1 Samuel K. Bouchillon, 2 Meredith Hackel, 2 Douglas J. Biedenbach, 2 Stephen Hawser, 1 Daryl Hoban 2 and Robert E.
|
|
- Rolf Sherman
- 5 years ago
- Views:
Transcription
1 Journal of Medical Microbiology (2014), 63, DOI /jmm Evaluation of the Clinical and Laboratory Standards Institute phenotypic confirmatory test to detect the presence of extended-spectrum b-lactamases from 4005 Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae and Proteus mirabilis isolates Ian Morrissey, 1 Samuel K. Bouchillon, 2 Meredith Hackel, 2 Douglas J. Biedenbach, 2 Stephen Hawser, 1 Daryl Hoban 2 and Robert E. Badal 2 Correspondence Ian Morrissey imorrissey@ihmainc.com Received 30 September 2013 Accepted 29 January IHMA Europe Sàrl, 1066 Epalinges, Switzerland 2 International Health Management Associates, Schaumburg, IL , USA A subset of Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae and Proteus mirabilis isolates collected for the Study for Monitoring Antimicrobial Resistance Trends that were positive for the Clinical and Laboratory Standards Institute (CLSI) extended-spectrum b-lactamase (ESBL) phenotypic confirmatory test (n53245) or had an ertapenem MIC of 0.5 mg ml 1 (n5293), or both (n5467), were analysed for ESBL genes. Most ESBL phenotype E. coli or K. pneumoniae possessed an ESBL gene (95.8 and 88.4 %, respectively), and this was 93.1 % if carbapenem-non-susceptible K. pneumoniae were removed. This rate was lower for P. mirabilis (73.4 %) and K. oxytoca (62.5 %). Virtually all ESBL-positive isolates (99.5 %) were cefotaxime non-susceptible [CLSI or European Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoints)]. Fewer isolates (82 %) were ceftazidime non-susceptible (CLSI breakpoints). In addition, 21.1 % of E. coli,25%ofk. oxytoca and 78.7 % of P. mirabilis isolates were ceftazidime susceptible but ESBL positive. This suggests that CLSI breakpoints for ceftazidime are too high to detect ESBLs. The lower EUCAST breakpoints detected ESBLs in E. coli and K. oxytoca better, but 59.6 % of ESBL-positive isolates of P. mirabilis were ceftazidime susceptible. For isolates with ertapenem MICs 0.5 mg ml 1, more accurate ESBL phenotype analysis was observed for E. coli and K. pneumoniae (sensitivity.95 % for both, specificity 94.4 and 54.1 %, respectively). If carbapenemase-positive K. pneumoniae were excluded, the specificity increased to 78 %. The positive predictive values for the ESBL phenotypic test with E. coli and K. pneumoniae were 97.6 and 81.8 %, respectively, and negative predictive values were 75.9 and 95.2 %, respectively. We therefore suggest that it would be prudent to confirm phenotypic ESBLpositive P. mirabilis, K. pneumoniae and K. oxytoca with molecular analysis. INTRODUCTION It is well established that extended-spectrum b-lactamases (ESBLs) are an important clinical issue, and their presence can have serious medical implications and associated healthcare costs (Solomkin et al., 1990; Walsh et al., 2005). Abbreviations: CLSI, Clinical and Laboratory Standards Institute; ESBL, extended-spectrum b-lactamase; EUCAST, European Committee on Antimicrobial Susceptibility Testing; SMART, Study for Monitoring Antimicrobial Resistance Trends. Eight supplementary tables are available with the online version of this paper. Furthermore, the prevalence of ESBLs has been increasing steadily over the last 10 years or so (Leclerc et al., 2011). Since 2010, both the Clinical and Laboratory Standards Institute (CLSI, 2010) and the European Committee on Antimicrobial Susceptibility Testing (EUCAST, 2013) have reduced the breakpoints for most cephalosporins against Enterobacteriaceae and as a consequence no longer recommend specific testing for ESBL presence or adjustment of penicillin, cephalosporin or monobactam susceptibility accordingly (Leclerc et al., 2011), unless clinical laboratories are using automated systems that retain the older higher CLSI breakpoints (CLSI, 2012a). Although there is a G 2014 SGM Printed in Great Britain
2 Evaluation of the CLSI ESBL phenotypic test Table 1. Isolates included in the study by species, year of collection, infection and geographical region Characteristic E. coli K. oxytoca K. pneumoniae P. mirabilis Total Year Infection Intra-abdominal Urinary tract Unknown Region Africa Asia Europe Latin America Middle East North America South Pacific Overall total common recommendation not to routinely test for ESBLs from both of the two main antimicrobial resistance expert groups in the world, the decision to exclude ESBL detection is not without controversy (Livermore et al., 2012).It has also been suggested that CLSI ESBL phenotypic confirmatory tests are unable to detect the presence of ESBLs if AmpC enzymes are also present (Munier et al., 2010). Recently, the use of CLSI or EUCAST disk diffusion methodology breakpoints was shown to be better than CLSI MIC ESBL screening breakpoints for the detection of ESBLs, especially those isolates having an AmpC b-lactamase, using a panel of 236 well-characterized isolates (Polsfuss et al., 2012). As a consequence, Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae and Proteus mirabilis isolates (n54005) from the Study for Monitoring Antimicrobial Resistance Trends (SMART) were assessed to correlate the CLSI ESBL phenotypic test, susceptibility to cefotaxime and ceftazidime (EUCAST and CLSI breakpoints), and molecular characterization of the b-lactamase genes detected. METHODS Study isolates. All isolates in the study were from intra-abdominal ( ) or urinary tract infections ( ), and only one isolate per species per patient was accepted. All organisms were deemed clinically significant based on the local participants criteria. Isolate inclusion was independent of antimicrobial use, age or gender. The isolates were identified to species level at each site, and sent to a central laboratory (International Health Management Associates, Schaumburg, Illinois, USA) for confirmation of identification using a RapidOne panel (Remel) and antimicrobial susceptibility testing. International Health Management Associates managed the development of a centralized database of the study results. The isolates were collected between 2008 and 2011 from various countries worldwide. Isolate details are given in Table 1. Susceptibility testing. MIC values were determined using custom MicroScan dehydrated broth microdilution panels (Siemens Medical Solutions Diagnostics), following CLSI (2012b) and the manufacturer s guidelines. For the purpose of inclusion in this analysis, MIC data for the following antimicrobial agents (with their dilution ranges expressed in mg ml 21 ) were used: ertapenem, ; ceftazidime, ; ceftazidime clavulanic acid, ; cefotaxime, ; cefotaxime clavulanic acid, MICs were interpreted following CLSI (2012a) and EUCAST (2013) guidelines. CLSI phenotypic confirmatory test to detect the presence of ESBL. Following CLSI guidelines, Enterobacteriaceae were classified as ESBL producers (hereafter referred to as pesbl positive) if there was at least an eightfold reduction (i.e. three doubling dilutions) of the MIC for ceftazidime or cefotaxime in combination with clavulanic acid versus their MICs when tested alone (CLSI 2012a). Where MIC Table 2. Isolates included in the study by ertapenem MIC and pesbl positive Species Ertapenem MIC 0.5 mg ml 1 but non-esbl phenotype ESBL phenotype, including ertapenem MIC 0.5 mg ml 1 Total E. coli K. pneumoniae K. oxytoca P. mirabilis Total
3 I. Morrissey and others Table 3. Molecular detection of ESBLs in 3712 pesblpositive isolates by species Species data were off scale (i.e. the MICs of cefotaxime and/or ceftazidime alone and with clavulanic acid were greater than the highest concentration tested on the panel), disk testing with ceftazidime (30 mg) or cefotaxime (30 mg) in combination with or without clavulanic acid (10 mg) was used according to CLSI (2012a) guidelines. Molecular characterization. DNA was extracted from overnight colonies of isolates positive for the ESBL phenotypic test or with an ertapenem MIC 0.5 mg ml 21 grown on blood agar (Remel) using a QIAamp DNA Mini kit and a QIAcube instrument (Qiagen). PCR for characterization of ESBLs was performed in an ABI 9700 thermocycler (Applied Biosystems). bla genes for TEM-, SHV-, CTX-M-, OXA-48-, metallo- (IMP, VIM, SPM, SIM, GIM and NDM) and KPC-type enzymes were amplified as described previously (Ellington et al., 2007; Livermore et al., 2007; Nordmann et al., 2009; Solomkin et al., 1990; Walsh et al., 2005; Woodford et al., 2008). PCR was carried out with a Fast Cycling PCR kit (Qiagen). Purification of the PCR products was performed using Exo-SAP-IT (USB). PCR-amplified fragments were sequenced using an ABI 3730XL DNA analyser (Applied Biosystems). Nucleotide sequences were analysed with SeqScape v.7.0 (Applied Biosystems) and compared with sequences available at the National Center for Biotechnology Information website ( nih.gov). Multiplex amplification of pampc genes was performed as described previously by Pérez-Pérez & Hanson (2002). Quality control. Quality control was performed each day of testing using the CLSI-recommended quality control strains E. coli ATCC 25922, E. coli ATCC and K. pneumoniae ATCC (ESBLpositive control). Results were included in the analysis only when the corresponding quality control isolates tested within the acceptable ranges according to CLSI (2012a) guidelines. RESULTS mesbl negative [n (%)] mesbl positive [n (%)] K. pneumoniae 138 (11.7) 1045 (88.3) E. coli 102 (4.2) 2299 (95.8) K. oxytoca 24 (37.5) 40 (62.5) P. mirabilis 17 (26.6) 47 (73.4) Total 281 (7.5) 3431 (92.5) Susceptibility testing and ESBL confirmatory test Of the 3712 pesbl-positive isolates, 3671 were identified by MIC testing and 41 isolates required in addition disk susceptibility testing (data not shown). The 3712 pesblpositive isolates comprised 3245 isolates with ertapenem MICs,0.5 mg ml 21 and 467 isolates with ertapenem MICs 0.5 mg ml 21. In addition, there were 293 isolates with ertapenem MICs 0.5 mg ml 21 but that were non-esbl phenotype. These results are summarized in Table 2. These 4005 isolates were subjected to molecular analysis for detection of ESBLs and other b-lactamase genes. Molecular analysis of ESBL phenotypes The majority of the 3712 pesbl positive contained an ESBL gene (hereafter referred to as mesbl positive; 92.5 % in total). A larger proportion was observed in E. coli (95.9 %), and fewer were found in the other bacterial species, especially K. oxytoca (62.5 %) (Table 3). A breakdown of the ESBL enzymes is shown in Table S1 (available in the online Supplementary Material), with the most common ESBL being CTX-M. Further details of the ESBL enzymes detected are given in Tables S2 S6. The highest number of false-positive pesbl isolates was found in K. pneumoniae (n5138, Table 3), and 42.1 % of these possessed a carbapenemase (Tables 4 and S7). As would be expected, all 56 carbapenemase-positive K. pneumoniae isolates were ertapenem non-susceptible (results not shown), and if these were included within the pesbl-positive population, the detection success for the ESBL phenotype test for K. pneumoniae increased to 93.1 % (data not shown). Very few of the other bacterial species that were pebsl positive actually possessed a b- lactamase (Table 4), and of these the majority were AmpCs (Table S8), plus two K. oxytoca with KPC-2. None of the pebsl-positive (but mesbl-negative) isolates possessed more than one b-lactamase. Cefotaxime and ceftazidime susceptibility of ESBL phenotypes The summary MIC and susceptibility data for cefotaxime and ceftazidime against mesbl-positive Enterobacteriaceae are shown in Table 5. Both CLSI and EUCAST have identical breakpoints for cefotaxime and these classified.95 % of the mesbl-positive species as cefotaxime non-susceptible. However, for ceftazidime, detection was poor, with only 21.2 % of P. mirabilis isolates found to be non-susceptible by Table 4. Presence of other b-lactamases in mesbl-negative isolates Species mesbl-negative (n) No. of isolates [n (%)] with b-lactamase: AmpC Carbapenemase No mechanism K. pneumoniae (3.0) 56 (42.1) 73 (54.9) E. coli (9.8) 3 (2.9) 89 (87.3) K. oxytoca 24 1 (4.2) 2 (8.3) 21 (87.5) P. mirabilis 17 1 (5.9) 0 (0.0) 16 (94.1) Total (5.7) 61 (21.8) 203 (72.5) 558 Journal of Medical Microbiology 63
4 Evaluation of the CLSI ESBL phenotypic test Table 5. Summary MIC and susceptibility data for cefotaxime and ceftazidime against mesbl-positive Enterobacteriaceae Antibiotic Species (n) MIC (mg ml 1 )* CLSI breakpointsd EUCAST breakpointsd MIC 50 MIC 90 S (%) I (%) R (%) S (%) I (%) R (%) Cefotaxime Escherichia coli (2299) Klebsiella oxytoca (40) Klebsiella pneumoniae (1045) Proteus mirabilis (47) All (3431) Ceftazidime Escherichia coli (2299) Klebsiella oxytoca (40) Klebsiella pneumoniae (1045) Proteus mirabilis (47) All (3431) S, Susceptible; I, intermediate; R, resistant. *MIC 50, MIC inhibiting 50 % of the bacterial species; MIC90, MIC inhibiting 90 % of the bacterial species. DCLSI S/I/R breakpoints are 1/2/4 for cefotaxime, and 4/8/16 for ceftazidime. deucast S/I/R breakpoints are 1/2/4 for cefotaxime, and 1/2/4 for ceftazidime. CLSI breakpoints (or 40.4 % by EUCAST breakpoints). In addition, detection of mesbl-positive E. coli (79 %) or K. oxytoca (75 %) with CLSI breakpoints for ceftazidime was much weaker than that seen with cefotaxime. Only ESBLs in K. pneumoniae were adequately detected by ceftazidime MIC values (Table 5). Molecular analysis of isolates with ertapenem MICs 0.5 mg ml 1 Although ertapenem susceptibility is not related to ESBL phenotype per se, this subset was analysed because it included pesbl-negative isolates as well as pesbl-positive isolates (unlike the other bacteria evaluated in this paper). Of the 760 isolates tested, 547 were pesbl positive and 213 were pesbl negative (Table 6). Most of the isolates were E. coli or K. pneumoniae, and these were analysed further for specificity, sensitivity, positive predictive value and negative predictive value(table7).thephenotypicscreenperformedwellagainst E. coli but specificity was poor against K. pneumoniae. As indicated above this problem could be resolved by removing the carbapenemase-positive strains (Table 7). However, in practice, this would require an additional phenotypic screen. However, the CLSI phenotypic test was not as good at detecting true ESBLs from K. pneumoniae, where 137 isolates of this species (11.6 %) were incorrectly identified as ESBL positive; 56 of these were shown to possess a carbapenemase (all of which had an ertapenem MIC 0.5 mg l 21 ). From broth microdilution MICs, more than 99 % of the molecularly confirmed ESBL-positive E. coli and K. pneumoniae were found to be cefotaxime nonsusceptible. Therefore, for these species, it is probably not necessary to undertake further molecular analysis if the cefotaxime MIC is determined, unless for epidemiological or infection control purposes. In contrast, ceftazidime CLSI non-susceptibility was much weaker at predicting ESBLs with E. coli (21.1 % ESBL-positive E. coli were ceftazidime susceptible); therefore, the ceftazidime MIC should not be used as a single marker for the presence of ESBLs according to CLSI breakpoints for E. coli. The lower EUCAST breakpoints for ceftazidime, on the other hand, were able to detect 95 % of the ESBL-positive E. coli, in agreement with the findings of Polsfuss et al. (2012). This suggests that the CLSI ceftazidime breakpoints are too high to be used as a marker for ESBLs, and that they may be more useful if lowered to match those used by EUCAST. The ceftazidime DISCUSSION In this study, we analysed a total of 4005 clinical isolates of E. coli, K. oxytoca, K. pneumoniae and P. mirabilis from SMART worldwide during These isolates were screened as part of SMART for the presence of b-lactamase genes either because they were positive for ESBLa using the CLSI phenotypic test or because they had an ertapenem MIC 0.5 mg ml 21. The data indicated that, for E. coli, the CLSI phenotypic screen correctly identified 95.8 % as having an ESBL gene. Table 6. ESBL phenotypes for 760 isolates with ertapenem MICs 0.5 mg ml 1 by species Species Phenotype negative [n (%)] Phenotype positive [n (%)] Total (n) E. coli 72 (26.0) 205 (74.0) 277 K. oxytoca 3 (27.3) 8 (72.7) 11 K. pneumoniae 136 (29.0) 333 (71.0) 469 P. mirabilis 2 (66.7) 1 (33.3) 3 Total 213 (28.0) 547 (72.0)
5 I. Morrissey and others Table 7. Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) for the CLSI phenotypic test for E. coli and K. pneumoniae with ertapenem MICs 0.5 mg ml 1 Species True positive False negative False positive True negative Sensitivity* SpecificityD PPVd NPV E. coli K. pneumoniae K. pneumoniae (carbapenemase negative) *Sensitivity5true positive/(true positive+false negative). DSpecificity5true negative/(true negative+false positive). dppv5true positive/(true positive+false positive). NPV5true negative/(true negative+false negative). susceptibility for K. pneumoniae by CLSI breakpoints, on the other hand, was adequate to detect ESBLs in this species. For K. oxytoca and P. mirabilis, a larger number of ESBL false-positive isolates was seen when using the CLSI phenotype (37.5 and 26.5 %, respectively) than for E. coli (4.2 %) and K. pneumoniae (11.7 %). There was no evidence that this was caused by potential interference with other b-lactamases, including AmpC (Munier et al., 2010). Use of cefotaxime non-susceptibility alone was able to detect.95 % of the ESBL true-positive isolates. Similarly to E. coli, ESBL-positive K. oxytoca isolates were not adequately detected by ceftazidime susceptibility using CLSI breakpoints but were with EUCAST breakpoints. For P. mirabilis, neither CLSI nor EUCAST breakpoints for ceftazidime were able to adequately detect ESBL-positive isolates (78.7 % ESBL-positive P. mirabilis isolates were susceptible according to CLSI ceftazidime breakpoints and 59.6 % by EUCAST). This result does not agree with the findings of Polsfuss et al. (2012), but in their study, only two P. mirabilis isolates were investigated, making it difficult to draw conclusions about this species. To summarize, the CLSI ESBL phenotypic test predicted the presence of an ESBL gene well for E. coli and K. pneumoniae (except those that were ertapenem nonsusceptible), as did cefotaxime susceptibility, but not ceftazidime susceptibility alone especially for P. mirabilis. False-positive results were obtained more often with P. mirabilis and K. oxytoca. Therefore, we suggest that it may be prudent to confirm phenotypically ESBL-positive P. mirabilis, K. pneumoniae and K. oxytoca by additional molecular or other analyses. It may also be worthwhile reconsidering the CLSI breakpoints for ceftazidime against Enterobacteriaceae. ACKNOWLEDGEMENTS We thank all the SMART investigators for their participation in this programme. We are also grateful to Dr Christine Lascols for her participation in the molecular analysis for this publication. The SMART surveillance programme is funded by Merck & Co.. All authors have served as scientific advisors or consultants to Merck, and received research support from Merck to conduct this study. REFERENCES CLSI (2010). Performance Standards for Antimicrobial Susceptibility Testing; 20th Informational Supplement M100-S20. Wayne, PA: Clinical and Laboratory Standards Institute. CLSI (2012a). Performance Standards for Antimicrobial Susceptibility Testing; 22nd Informational Supplement M100-S22. Wayne, PA: Clinical and Laboratory Standards Institute. CLSI (2012b). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard, 9th edn, M7- A9. Wayne, PA: Clinical and Laboratory Standards Institute. Ellington, M. J., Kistler, J., Livermore, D. M. & Woodford, N. (2007). Multiplex PCR for rapid detection of genes encoding acquired metallo-b-lactamases. J Antimicrob Chemother 59, EUCAST (2013). EUCAST Clinical Breakpoints v.3. European Committee on Antimicrobial Susceptibility Testing. eucast.org/clinical_breakpoints/. Leclercq, R., Cantón, R., Brown, D. F., Giske, C. G., Heisig, P., MacGowan, A. P., Mouton, J. W., Nordmann, P., Rodloff, A. C. & other authors (2011). EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect 19, Livermore, D. M., Canton, R., Gniadkowski, M., Nordmann, P., Rossolini, G. M., Arlet, G., Ayala, J., Coque, T. M., Kern-Zdanowicz, I. & other authors (2007). CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 59, Livermore, D. M., Andrews, J. M., Hawkey, P. M., Ho, P. L., Keness, Y., Doi, Y., Paterson, D. & Woodford, N. (2012). Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly? J Antimicrob Chemother 67, Munier, G. K., Johnson, C. L., Snyder, J. W., Moland, E. S., Hanson, N. D. & Thomson, K. S. (2010). Positive extended-spectrum-blactamase (ESBL) screening results may be due to AmpC b-lactamases more often than to ESBLs. J Clin Microbiol 48, Nordmann, P., Cuzon, G. & Naas, T. (2009). The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 9, Pérez-Pérez, F. J. & Hanson, N. D. (2002). Detection of plasmidmediated AmpC b-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 40, Polsfuss, S., Bloemberg, G. V., Giger, J., Meyer, V. & Hombach, M. (2012). Comparison of European Committee on Antimicrobial 560 Journal of Medical Microbiology 63
6 Evaluation of the CLSI ESBL phenotypic test Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum b-lactamase production in clinical Enterobacteriaceae isolates. J Antimicrob Chemother 67, Solomkin, J. S., Dellinger, E. P., Christou, N. V. & Busuttil, R. W. (1990). Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections. Ann Surg 212, Walsh, T. R., Toleman, M. A., Poirel, L. & Nordmann, P. (2005). Metallo-b-lactamases: the quiet before the storm? Clin Microbiol Rev 18, Woodford, N., Zhang, J., Warner, M., Kaufmann, M. E., Matos, J., Macdonald, A., Brudney, D., Sompolinsky, D., Navon-Venezia, S. & Livermore, D. M. (2008). Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom. J Antimicrob Chemother 62,
Why the CDS? The unique advantages of using an Australian antimicrobial susceptibility testing method
Why the CDS? The unique advantages of using an Australian antimicrobial susceptibility testing method Peter Newton Medical Microbiologist Wollongong Hospital, Wollongong, NSW Where do I come from? SEALS
More informationThe Genetic Epidemiology of Antibiotic Resistance
The Genetic Epidemiology of Antibiotic Resistance Professor Neil Woodford Antimicrobial Resistance & Healthcare Associated Infections (AMRHAI) Reference Unit Crown copyright The forensics of AMR Resistance
More informationAntibiotic Resistance in Enterobacteriaceae
Antibiotic Resistance in Enterobacteriaceae Prof. P. Nordmann 16 es JNI, Nancy, du 10 au 12 juin 2015 1 16 es JNI, Nancy, du 10 au 12 juin 2015 16 es JNI, Nancy, du 10 au 12 juin 2015 16 es JNI, Nancy,
More informationRapid detection of extended-spectrum ß-lactamase-producing. Enterobacteriaceae
JCM Accepts, published online ahead of print on 3 July 2012 J. Clin. Microbiol. doi:10.1128/jcm.00859-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Rapid detection of extended-spectrum
More informationValue of the Modified Hodge test for detection of emerging. carbapenemases in Enterobacteriaceae
JCM Accepts, published online ahead of print on 23 November 2011 J. Clin. Microbiol. doi:10.1128/jcm.05247-11 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions. All
More informationMost common dose (mg) 1g x 1 1g x 1 1g x 1 1g x 1 1g x 1 1g x 1. Maximum dose schedule (mg) 1g x 1 1g x 1 1g x 1 1g x 1 1g x 1 1g x 1
Ertapenem Rationale for the EUCAST clinical breakpoints, version 1.3 1 st June 2009 Introduction Ertapenem is a carbapenem, available only for parenteral use. Ertapenem is relevant for therapy of septicaemia,
More informationValidation of EUCAST zone diameter breakpoints against reference broth microdilution
ORIGINAL ARTICLE BACTERIOLOGY Validation of EUCAST zone diameter breakpoints against reference broth microdilution S. Bengtsson 1, C. Bjelkenbrant 1 and G. Kahlmeter 1,2 1) Department of Clinical Microbiology,
More informationBy Eliza Bielak Bacterial Genomics and Epidemiology, DTU-Food Supervised by Henrik Hasman, PhD
By Eliza Bielak Bacterial Genomics and Epidemiology, DTU-Food elibi@food.dtu.dk Supervised by Henrik Hasman, PhD 1. Introduction to plasmid biology 2. Plasmid encoded resistance to β- lactams (basic theories)
More informationPhenotypic and Molecular Characteristics of Carbapenem-Non-Susceptible Enterobacteriaceae from a Teaching Hospital in Wenzhou, Southern China
Jpn. J. Infect. Dis., 66, 96-102, 2013 Original Article Phenotypic and Molecular Characteristics of Carbapenem-Non-Susceptible Enterobacteriaceae from a Teaching Hospital in Wenzhou, Southern China Tieli
More informationTested Against Tigecycline and Agents Commonly Used for S. maltophilia Infections. David J. Farrell 1*, Helio S. Sader 1,2. and. Ronald N.
AAC Accepts, published online ahead of print on 5 April 2010 Antimicrob. Agents Chemother. doi:10.1128/aac.01774-09 Copyright 2010, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationby author What is new in EUCAST?
What is new in EUCAST? Christian G. Giske, MD/PhD Chair of EUCAST Chief consultant physician/assoc. professor Karolinska Institutet and Karolinska University Hospital ECCMID 2018, Madrid EUCAST SC 2018
More informationEscherichia coli O26 9
15 Vero b- (ESBL) Escherichia coli O26 1 1) 1) 2) 2) 2) 2) 3) 3) 1) 1) 2) 2 3) 16 10 18 16 12 17 Vero b- (Extended-spectrum b-lactamase: ESBL) Escherichia coli O26 9 2004 6 14 16 E. coli O O26 Vero VT1
More informationNitroxoline Rationale for the NAK clinical breakpoints, version th October 2013
Nitroxoline Rationale for the NAK clinical breakpoints, version 1.0 4 th October 2013 Foreword NAK The German Antimicrobial Susceptibility Testing Committee (NAK - Nationales Antibiotika-Sensitivitätstest
More informationESCMID Online Lecture Library
E. coli producing extendedspectrum β lactamases Luis Martínez Martínez Dept. Molecular Biology, University of Cantabria Service of Microbiology Hosp. Univ. Marqués de Valdecilla Santander, Spain Barcelona
More informationby author ESCMID Online Lecture Library Epidemiological cutoff values (ECOFFs) and Low Level resistance Gunnar Kahlmeter
Epidemiological cutoff values (ECOFFs) and Low Level resistance ECCMID 2010 Gunnar Kahlmeter Sweden Gunnar.Kahlmeter@ltkronoberg.se The epidemiological cutoff value ECOFF When breakpoints fail to detect
More informationAAC Accepts, published online ahead of print on 20 August 2007 Antimicrob. Agents Chemother. doi: /aac
AAC Accepts, published online ahead of print on 20 August 2007 Antimicrob. Agents Chemother. doi:10.1128/aac.00614-07 Copyright 2007, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationResistance to third-generation cephalosporins in human non-typhoidal Salmonella enterica isolates from England and Wales,
Royal College of Surgeons in Ireland e-publications@rcsi Clinical Microbiology Articles Department of Clinical Microbiology 1-4-2014 Resistance to third-generation cephalosporins in human non-typhoidal
More informationTetracycline Rationale for the EUCAST clinical breakpoints, version th November 2009
Tetracycline Rationale for the EUCAST clinical breakpoints, version 1.0 20 th November 2009 Introduction The natural tetracyclines, including tetracycline, chlortetracycline, oxytetracycline and demethylchlortetracycline
More informationDetection of carbapenemase producers in Enterobacteriaceae. using a novel screening medium
JCM Accepts, published online ahead of print on 22 February 2012 J. Clin. Microbiol. doi:10.1128/jcm.06477-11 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Detection of carbapenemase
More informationIncreasing Carbapenem-Resistant Gram-Negative Bacilli and Decreasing Metallo-β-Lactamase Producers over Eight Years from Korea
Brief Communication http://dx.doi.org/10.3349/ymj.2015.56.2.572 pissn: 0513-5796, eissn: 1976437 Yonsei Med J 56(2):572-577, 2015 Increasing Carbapenem-Resistant Gram-Negative Bacilli and Decreasing Metallo-β-Lactamase
More informationAntimicrobial Activities of Ceftazidime/Avibactam and Comparator Agents against Clinical. Bacteria Isolated from Patients with Cancer.
AAC Accepted Manuscript Posted Online 23 January 2017 Antimicrob. Agents Chemother. doi:10.1128/aac.02106-16 Copyright 2017 American Society for Microbiology. All Rights Reserved. 1 2 Antimicrobial Activities
More informationImplementation of Public Health Surveillance of Carbapenemase- Producing Enterobacteriaceae in Victoria, Australia
Implementation of Public Health Surveillance of Carbapenemase- Producing Enterobacteriaceae in Victoria, Australia C.R. Lane*, J. Brett, M.B. Schultz, K. Stevens, A. van Diemen, S.A. Ballard, N.L. Sherry,
More informationToronto General Hospital ANTIBIOGRAM Emergency Department January 1, December 31, 2016
IV (meningitis) IV (non-meningitis) (meningitis) (non-meningitis) Blood Isolates % Susceptible 644 18 36 70 78 74 59 69 75 262 100 19 64 75 100 92 54 72 78 76 68 89 86 99 Escherichia coli 153 58 30 67
More informationGentamicin Rationale for the EUCAST clinical breakpoints, version th February, 2009
Gentamicin Rationale for the EUCAST clinical breakpoints, version 1.2 16 th February, 2009 Introduction The aminoglycosides are a group of naturally occurring or semi-synthetic compounds with bactericidal
More informationANTIMICROBIAL TESTING. E-Coli K-12 - E-Coli 0157:H7. Salmonella Enterica Servoar Typhimurium LT2 Enterococcus Faecalis
ANTIMICROBIAL TESTING E-Coli K-12 - E-Coli 0157:H7 Salmonella Enterica Servoar Typhimurium LT2 Enterococcus Faecalis Staphylococcus Aureus (Staph Infection MRSA) Streptococcus Pyrogenes Anti Bacteria effect
More informationb-lactam resistance and b-lactamase expression in clinical Stenotrophomonas maltophilia isolates having defined phylogenetic relationships
Journal of Antimicrobial Chemotherapy Advance Access published December 13, 2005 Journal of Antimicrobial Chemotherapy doi:10.1093/jac/dki453 b-lactam resistance and b-lactamase expression in clinical
More informationCharacterization of Class 1 Integrons and Antimicrobial Resistance in CTX-M-3-Producing Serratia marcescens Isolates from Southern Taiwan
Jpn. J. Infect. Dis., 60, 250-256, 2007 Original Article Characterization of Class 1 Integrons and Antimicrobial Resistance in CTX-M-3-Producing Serratia marcescens Isolates from Southern Taiwan Chien-Fang
More informationCharacteristics of extended-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates from horses
Veterinary Microbiology 124 (2007) 248 255 www.elsevier.com/locate/vetmic Characteristics of extended-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates from horses An
More informationBMR nouveaux antibiotiques Dubreuil, PhD, PharmD - LIRIC UMR 995 Inserm/Université Lille France
BMR nouveaux antibiotiques Dubreuil, PhD, PharmD - LIRIC UMR 995 Inserm/Université Lille France Lille Octobre 2016 Bad bugs need new drug MRSA LIRIC UMR 995 Dubreuil L S. pneumoniae SFM Mars 2016 Adverse
More informationScreening Extended-spectrum b-lactamase Production in Enterobacter cloacae and Serratia marcescens Using Antibiogram-based Methods
J Microbiol Immunol Infect 2010;43(1):26 34 Contents lists available at ScienceDirect Journal of Microbiology, Immunology and Infection Journal homepage: http://www.e-jmii.com Original Article Screening
More informationReceived 3 April 2002; returned 19 August 2002; revised 4 November 2002; accepted 25 November 2002
Journal of Antimicrobial Chemotherapy (2003) 51, 631 638 DOI: 10.1093/jac/dkg103 Advance Access publication 11 February 2003 Production of CTX-M-3 extended-spectrum β-lactamase and IMP-1 metallo β-lactamase
More informationResistance of Escherichia coli and Salmonella typhimurium to Carbenicillin
J. gen. Microbiol. (1969, 58, 301-305 Printed in Great Britain 301 Resistance of Escherichia coli and Salmonella typhimurium to Carbenicillin By H. C. NEU AND H. S,WARZ Department of Medicine, College
More informationAntibiotic Resistance in Escherichia coli Iron Transport Mutants
Bowling Green State University ScholarWorks@BGSU Honors Projects Honors College Fall 12-11-2017 Antibiotic Resistance in Escherichia coli Iron Transport Mutants Madeline Brandt mbrandt@bgsu.edu Follow
More informationENTEROBACTER AEROGENES UNKNOWN BACTERIA FLOW CHART UNKNOWN LAB REPORT, MICROBIOLOGY ENTEROBACTER AEROGENES
ENTEROBACTER AEROGENES UNKNOWN BACTERIA PDF UNKNOWN LAB REPORT, MICROBIOLOGY ENTEROBACTER AEROGENES IDENTIFICATION OF AN UNKNOWN BACTERIAL SPECIES OF 1 / 5 2 / 5 3 / 5 enterobacter aerogenes unknown bacteria
More informationEmergence of CTX-M-15 type extended-spectrum b-lactamase-producing Salmonella spp. in Kuwait and the United Arab Emirates
Journal of Medical Microbiology (2008), 57, 881 886 DOI 10.1099/jmm.0.47509-0 Emergence of CTX-M-15 type extended-spectrum b-lactamase-producing Salmonella spp. in Kuwait and the United Arab Emirates Vincent
More informationNew Delhi Metallo-Beta-Lactamase- Producing Enterobacteriaceae in. South Korea Between 2010 and 2015 INTRODUCTION
ORIGINAL RESEARCH published: 29 March 2018 doi: 10.3389/fmicb.2018.00571 New Delhi Metallo-Beta-Lactamase- Producing Enterobacteriaceae in South Korea Between 2010 and 2015 Eun-JeongYoon 1,DaYoungKang
More informationTelithromycin in vitro
in vitro Telithromycin in vitro MBCMIC Staphylococcus aureus Enterococcus faecalis0 Streptococcus pneumoniae Haemophilus influenzae telithromycin MIC MBC erythromycin Aclarithromycin azithromycin josamycin
More informationEmergence of colistin resistance in Gram-negative bacteria
Emergence of colistin resistance in Gram-negative bacteria Youri GLUPCZYNSKI Daniel Te-Din HUANG Pierre BOGAERTS CHU UCL Namur Dinant-Godinne Clinical Microbiology Laboratory National Reference Centre
More informationReport: antimicrobial resistance in commensal E. coli from poultry, pigs, cows and veal calves. 2014
CODA-CERVA Report: antimicrobial resistance in commensal E. coli from poultry, pigs, cows and veal calves. 2014 Vicky Jasson and Pierre Wattiau Veterinary and Agrochemical Research Centre 1 Introduction
More informationSupporting information
Electronic Supplementary Material (ESI) for Organic & Biomolecular Chemistry. This journal is The Royal Society of Chemistry 209 Supporting information Na 2 S promoted reduction of azides in water: Synthesis
More informationComparisons of CTX-M-Producing Escherichia coli Isolates from Humans and Animals in South Korea
Journal of Bacteriology and Virology 2014. Vol. 44, No. 1 p.44 51 http://dx.doi.org/10.4167/jbv.2014.44.1.44 Original Article Comparisons of CTX-M-Producing Escherichia coli Isolates from Humans and Animals
More informationOrbital Diagnostics: Rapid antibiotic sensitivity determination. Dr Robert J H Hammond
Orbital Diagnostics: Rapid antibiotic sensitivity determination Dr Robert J H Hammond Lord Rutherford You can plan research. you cannot plan discovery The reality of clinical bacteriology diagnostics How
More informationμ gyra parc Escherichia coli Klebsiella pneumoniae Pseudomonas aeruginosa E. coli gyra E. coli parc gyra parc gyra Escherichia coli E. coli E.
gyra parc Escherichia coli Klebsiella pneumoniae Pseudomonas aeruginosa E. coli μ E. coli gyra parc gyra parc gyra parc μ μ gyra parc Key words Escherichia coli gyra parc Escherichia coli E. coli gyra
More informationComparative evaluation of the VITEK 2 Advanced Expert System (AES) in five UK hospitals
Journal of Antimicrobial Chemotherapy (2003) 51, 1191 1202 DOI: 10.1093/jac/dkg234 Advance Access publication 14 April 2003 Comparative evaluation of the VITEK 2 Advanced Expert System (AES) in five UK
More informationMost common dose (mg) 1 g x 3 1 g x mg -1.0 g x 3 1 g x mg -1 g x mg -1 g x 3
Meropenem Rationale for the EUCAST clinical breakpoints, version 1.5 1 st June 2009 Introduction Meropenem is a carbapenem, available only for parenteral use. Meropenem is relevant for therapy of septicaemia,
More informationREVIEW. Extended-spectrum b-lactamases and the permeability barrier
REVIEW Extended-spectrum b-lactamases and the permeability barrier L. Martínez-Martínez Service of Microbiology, University Hospital Marqués de Valdecilla, Santander, Spain ABSTRACT The outer membrane
More informationUse of the 3M Molecular Detection System for Salmonella and Listeria spp.
Use of the 3M Molecular Detection System for Salmonella and Listeria spp. March 11, 213 Prof Steve Forsythe Pathogen Research Centre, School of Science and Technology Nottingham Trent University Clifton
More informationStability. Received for publication 1 August to be fl-lactamase-producing strains.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Apr. 1978, p. 584-588 0066-4804/78/0013-0584$02.00/0 Copyright X) 1978 American Society for Microbiology Vol. 13, No. 4 Printed in U.S.A. Cefaclor: In Vitro Spectrum
More informationLow intestinal colonization of Escherichia coli clone ST131 producing CTX-M-15 in Jordanian infants
Journal of Medical Microbiology (2016), 65, 137 141 DOI 10.1099/jmm.0.000210 Low intestinal colonization of Escherichia coli clone ST131 producing CTX-M-15 in Jordanian infants E. F. Badran, 1 R. A. Qamer
More informationExpression characteristics of the plasmid-borne mcr-1 colistin resistance gene
/, 2017, Vol. 8, (No. 64), pp: 107596-107602 Expression characteristics of the plasmid-borne mcr-1 colistin resistance gene Haifang Zhang 1,*, Minhui Miao 1,*, Jieting Yan 1,*, Min Wang 1, Yi-Wei Tang
More informationObjectives. Epidemiology of AB resistance in S. pneumoniae. Pasteur Institute (R. Vanhoof) AB resistance evaluation (MIC) & mechanisms
Epidemiological survey of susceptibility to β-lactams, macrolides, and fluoroquinolones in a Belgian collection of Streptococcus pneumoniae isolated from patients with CAP A. Lismond, S. Carbonnelle, F.
More informationReading guide. EUCAST disk diffusion method for antimicrobial susceptibility testing. Version 2.0 May 2012
Reading guide EUCAST disk diffusion method for antimicrobial susceptibility testing Version 2.0 May 2012 Modifications to EUCAST reading guide slide show Version Version 2.0 May 2012 Version 1.1 December
More informationExpansion of Salmonella Typhimurium ST34 clone carrying multiple. resistance determinants in China
AAC Accepts, published online ahead of print on 24 June 2013 Antimicrob. Agents Chemother. doi:10.1128/aac.01174-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 2 Expansion
More informationReading guide. EUCAST disk diffusion method for antimicrobial susceptibility testing
Reading guide EUCAST disk diffusion method for antimicrobial susceptibility testing Version 3.0 April 2013 Modifications to EUCAST reading guide slide show Version Version 3.0 April 2013 Version 2.0 May
More informationReceived 1 November 2011; returned 25 November 2011; revised 30 November 2011; accepted 1 December 2011
J Antimicrob Chemother 2012; 67: 878 885 doi:10.1093/jac/dkr553 Advance Access publication 29 December 2011 Characterization of plasmids encoding extended-spectrum b-lactamases and their addiction systems
More informationReading guide. EUCAST disk diffusion method for antimicrobial susceptibility testing
Reading guide EUCAST disk diffusion method for antimicrobial susceptibility testing Version 4.0 June 2014 Modifications to EUCAST reading guide slide show Version Version 4.0 June 2014 Version 3.0 April
More informationOutbreak of a new serotype Salmonella enterica subsp. enterica, with antigenic formula 11:z 41 : e,n,z 15 in Greece :
Outbreak of a new serotype Salmonella enterica subsp. enterica, with antigenic formula 11:z 41 : e,n,z 15 in Greece : 2016-2017 An investigation of the Hellenic Centre of Disease Control and Prevention
More informationTHE IDENTIFICATION OF TWO UNKNOWN BACTERIA AFUA WILLIAMS BIO 3302 TEST TUBE 3 PROF. N. HAQUE 5/14/18
THE IDENTIFICATION OF TWO UNKNOWN BACTERIA AFUA WILLIAMS BIO 3302 TEST TUBE 3 PROF. N. HAQUE Introduction: The identification of bacteria is important in order for us to differentiate one microorganism
More informationPseudomonas putida 5
Pseudomonas putida 1 1 2 1 2 1 2 14 1 8 14 12 16 1997 1 21 12 5 Pseudomonas putida 8 27 imipenemipm IPM piperacillinceftazidimeamikacin norfloxacin 27 IPM IMP blaimp P. putida blaimp 27 8 9 4 1 MIC P.
More informationAlita Miller, PhD. Head of BioScience. April 24, 2017 ECCMID 2017 Vienna, Austria
ETX5 restoration of sulbactam activity against multidrug resistant Acinetobacter baumannii correlates with β-lactamase inhibition in vitro and in vivo Alita Miller, PhD Head of BioScience April, 07 ECCMID
More informationResearch Article Evaluation of Verigene Blood Culture Test Systems for Rapid Identification of Positive Blood Cultures
BioMed Volume 2016, Article ID 1081536, 6 pages http://dx.doi.org/10.1155/2016/1081536 Research Article Evaluation of Verigene Blood Culture Test Systems for Rapid Identification of Positive Blood Cultures
More informationZoo Animals as Reservoirs of Gram-Negative Bacteria Harboring Integrons and Antimicrobial Resistance Genes
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, Oct. 2007, p. 6686 6690 Vol. 73, No. 20 0099-2240/07/$08.00 0 doi:10.1128/aem.01054-07 Copyright 2007, American Society for Microbiology. All Rights Reserved. Zoo
More informationA multicenter surveillance of antimicrobial resistance in Serratia marcescens in Taiwan
Journal of Microbiology, Immunology and Infection (2014) 47, 387e393 Available online at www.sciencedirect.com journal homepage: www.e-jmii.com ORIGINAL ARTICLE A multicenter surveillance of antimicrobial
More informationGenomic characteristics of NDM-producing Enterobacteriaceae in
AAC Accepted Manuscript Posted Online 19 October 2015 Antimicrob. Agents Chemother. doi:10.1128/aac.01243-15 Copyright 2015, American Society for Microbiology. All Rights Reserved. 1 2 3 Genomic characteristics
More informationComparison of cefotiam and cefazolin activity against Gram-negative bacilli
Journal of Antimicrobial Chemotherapy (1979) 5, 681-685 Comparison of cefotiam and cefazolin activity against Gram-negative bacilli Michio Ogawa, Masayoshi Hama, Goro Kosaki Second Department of Surgery,
More information2 Salmonella Typhimurium
96 2006 Salmonella Typhimurium 2 1) 1) 2) 1) 2) 18 1 10 18 4 27 2 Salmonella Typhimurium 1 7 2 7 (ciprofloxacin (CPFX) MIC 16 mg/ml) S. Typhimurium 2 fosfomycin (FOM) 1 PCR gyra parc RAPD-PCR DNA S. Typhimurium
More informationACCEPTED. *Corresponding author. Mailing address: Faculdade de Medicina Veterinária, Av. da
AAC Accepts, published online ahead of print on 10 November 2008 Antimicrob. Agents Chemother. doi:10.1128/aac.00896-08 Copyright 2008, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationSerratia marcescens outbreak in a neonatal intensive care unit: crucial role of implementing hand hygiene among external consultants
Montagnani et al. BMC Infectious Diseases (2015) 15:11 DOI 10.1186/s12879-014-0734-6 RESEARCH ARTICLE Open Access Serratia marcescens outbreak in a neonatal intensive care unit: crucial role of implementing
More informationENTEROBACTER CLOACAE OUTER MEMBRANE PERMEABILITY TO CEFTIZOXIME (FK 749) AND FIVE OTHER NEW CEPHALOSPORIN DERIVATIVES
VOL. XXXIII NO. 3 THE JOURNAL OF ANTIBIOTICS 317 ENTEROBACTER CLOACAE OUTER MEMBRANE PERMEABILITY TO CEFTIZOXIME (FK 749) AND FIVE OTHER NEW CEPHALOSPORIN DERIVATIVES HITOSHI Kojo, YASUTAKA SHIGI and MINORU
More informationCharacterization of plasmids encoding bla ESBL and surrounding genes in Spanish clinical isolates of Escherichia coli and Klebsiella pneumoniae
Journal of Antimicrobial Chemotherapy (2009) 63, 60 66 doi:10.1093/jac/dkn453 Advance Access publication 6 November 2008 Characterization of plasmids encoding bla ESBL and surrounding genes in Spanish
More informationInhibitor Resistance in the KPC-2 -Lactamase: A. Pre-eminent Property of This Class A -Lactamase
AAC Accepts, published online ahead of print on 1 December 00 Antimicrob. Agents Chemother. doi:./aac.00-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationbelonging to the Genus Pantoea
Emerging diseases of maize and onion caused by bacteria belonging to the Genus Pantoea by Teresa Goszczynska Submitted in partial fulfilment of the requirements for the degree Philosophiae Doctoriae in
More informationINTRODUCTION MATERIALS & METHODS
Evaluation of Three Bacterial Transport Systems, The New Copan M40 Transystem, Remel Bactiswab And Medical Wire & Equipment Transwab, for Maintenance of Aerobic Fastidious and Non-Fastidious Organisms
More information3 S. Heidelberg ESBL Extended spectrum lactamase
Vol. 25 No. 123 almonella Heidelberg 1 almonella enterica serovar Heidelberg 1 3. Heidelberg EBL Extended spectrum lactamase CTX M 2 EBL. Heidelberg almonella enterica serovar Heidelberg 1 3. Heidelberg
More informationMulticenter Comparison of In Vitro Activities of FK-037, Cefepime, Ceftriaxone, Ceftazidime, and Cefuroxime
ANTIMICROBiAL AGENTS AND CHEMOTHERAPY, Aug. 3, p. 6-66-/93/6-5$./ Copyright 3, American Society for Microbiology Vol. 3, No. Multicenter Comparison of In Vitro Activities of,,,, and J. A. WASHINGTON,"*
More informationcefixime CFIX cefteram pivoxil CFTM-PI ceftriaxone CTRX cefodizime CDZM spectinomycin
00 3 STD JR 3 7 7 7 7 0 00 Neisseria gonorrhoeae 77 cefiximecfixcefteram pivoxilcftm-piceftriaxonectrxcefodizimecdzmspectinomycinspcmlevofloxacinlvfx CFIX MIC µ gml 0 pulsed-field gel electrophoresispfge00
More informationComparative Activity of Ampicillin and Cefuroxime Against
ANTIMICROBIAL AGENTS AND CHzMoTHzRAPY, Apr. 1977, p. 599-604 Copyright 0 1977 American Society for Microbiology Vol. 11, No. 4 Printed in U.S.A. Comparative Activity of Ampicillin and Cefuroxime Against
More informationKey words: Staphylococci, Classification, Antibiotic-susceptibility, Opportunistic infection
Key words: Staphylococci, Classification, Antibiotic-susceptibility, Opportunistic infection Table 1. Species classification of staphylococcal isolates from clinical specimens Figures in parentheses indicate
More informationCharacteristics of Plasmids in Multi-Drug-Resistant Enterobacteriaceae Isolated during Prospective Surveillance of a Newly Opened Hospital in Iraq
Characteristics of Plasmids in Multi-Drug-Resistant Enterobacteriaceae Isolated during Prospective Surveillance of a Newly Opened Hospital in Iraq Xiao-Zhe Huang 1 *., Jonathan G. Frye 2., Mohamad A. Chahine
More informationINTRODUCTION. In March 1998, the tender for project CT.98.EP.04 was awarded to the Department of Medicines Management, Keele University, UK.
INTRODUCTION In many areas of Europe patterns of drug use are changing. The mechanisms of diffusion are diverse: introduction of new practices by new users, tourism and migration, cross-border contact,
More informationAuthor(s) Yoshihiro; Kamihira, Shimeru; Kohno
NAOSITE: Nagasaki University's Ac Title Author(s) Citation Multiplex real-time polymerase chai lactamase-negative, ampicillin-resi Nakamura, Shigeki; Yanagihara, Kats Izumikawa, Koichi; Seki, Masafumi;
More informationOriginal Article Clinical Microbiology INTRODUCTION
Original Article Clinical Microbiology Ann Lab Med 2018;38:555-562 https://doi.org/10.3343/alm.2018.38.6.555 ISSN 2234-3806 eissn 2234-3814 Detection of mcr-1 Plasmids in Enterobacteriaceae Isolates From
More informationThe New England Journal of Medicine CEFTRIAXONE-RESISTANT SALMONELLA INFECTION ACQUIRED BY A CHILD FROM CATTLE
CEFTRIAXONE-RESISTANT SALMONELLA INFECTION ACQUIRED BY A CHILD FROM CATTLE PAUL D. FEY, PH.D., THOMAS J. SAFRANEK, M.D., MARK E. RUPP, M.D., EILEEN F. DUNNE, M.D., M.P.H., EFRAIN RIBOT, PH.D., PETER C.
More informationThe Clinical Aspects of β-lactam-resistant Stenotrophomonas
Yonago Acta medica 2003;46:91 102 The Clinical Aspects of -Lactam-Resistant Stenotrophomonas maltophilia Daisuke Kataoka and Yoshinori Tanaka Division of Microbiology, Department of Microbiology and Pathology,
More informationWhole genome sequencing (WGS) - there s a new tool in town. Henrik Hasman DTU - Food
Whole genome sequencing (WGS) - there s a new tool in town Henrik Hasman DTU - Food Welcome to the NGS world TODAY Welcome Introduction to Next Generation Sequencing DNA purification (Hands-on) Lunch (Sandwishes
More informationGlobal 3D Machine Vision Market Report- Forecast till 2022
Report Information More information from: https://www.marketresearchfuture.com/reports/1538 Global 3D Machine Vision Market Report- Forecast till 2022 Report / Search Code: MRFR/SEM/1009-HCRR Publish Date:
More informationMINIREVIEW. Growing Group of Extended-Spectrum -Lactamases: the CTX-M Enzymes. R. Bonnet*
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Jan. 2004, p. 1 14 Vol. 48, No. 1 0066-4804/04/$08.00 0 DOI: 10.1128/AAC.48.1.1 14.2004 MINIREVIEW Growing Group of Extended-Spectrum -Lactamases: the CTX-M Enzymes
More informationEUCAST Expert Rules Version 3.1. Intrinsic Resistance and Exceptional Phenotypes Tables
EUCAST Expert s Version 3.1 Intrinsic Resistance and Exceptional Phenotypes Tables EUCAST Expert s version 2.0 was published on 29 October 2011(http://www.eucast.org/expert_rules). The expert rules have
More informationSupporting Information for Bacterial Cheating Drives the Population Dynamics of Cooperative Antibiotic Resistance Plasmids
Supporting Information for Bacterial Cheating Drives the Population Dynamics of Cooperative Antibiotic Resistance Plasmids Eugene A. Yurtsev, Hui Xiao Chao, Manoshi Sen Datta, Tatiana Artemova and Jeff
More informationA Selective Medium for Bacillus anthracis
56 R~ORRIS, E. J. (955). J. gen. Microbiol. 3, 566 A Selective Medium for Bacillus anthracis BY E. J. MORRIS Microbiological Research Department, Ministry of Supply, Porton, Wiltshire SUMMARY: A medium
More informationPlasmid-encoded functions compensate for the biological cost of AmpC overexpression in a clinical isolate of Salmonella typhimurium
Journal of Antimicrobial Chemotherapy (2004) 53, 964 970 DOI: 10.1093/jac/dkh240 Advance Access publication 12 May 2004 Plasmid-encoded functions compensate for the biological cost of AmpC overexpression
More informationAntimicrobial Resistance in Haemophilus influenzae
CLINICAL MICROBIOLOGY REVIEWS, Apr. 2007, p. 368 389 Vol. 20, No. 2 0893-8512/07/$08.00 0 doi:10.1128/cmr.00040-06 Copyright 2007, American Society for Microbiology. All Rights Reserved. Antimicrobial
More informationSSI ENTERIC PRODUCT INFORMATION. Detects all Enterobacteria. Direct identification. Rapid diagnosis. Cost saving
SSI ENTERIC M E D I U M Detects all Enterobacteria Direct identification Rapid diagnosis Cost saving SSI Diagnostica 2 Herredsvejen 3400 Hillerød Denmark PRODUCT INFORMATION Tel: +45 4829 9100 Fax: +45
More informationINRA, UR1282, Infectiologie Animale et Santé Publique, IASP, Nouzilly, F-37380, France 1 ;
AAC Accepts, published online ahead of print on 1 July 0 Antimicrob. Agents Chemother. doi:./aac.000- Copyright 0, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.
More informationFitness constraints on horizontal gene transfer
Fitness constraints on horizontal gene transfer Dan I Andersson University of Uppsala, Department of Medical Biochemistry and Microbiology, Uppsala, Sweden GMM 3, 30 Aug--2 Sep, Oslo, Norway Acknowledgements:
More informationInvolvement of efflux pumps in the resistance to peptidoglycan synthesis
AAC Accepts, published online ahead of print on January 0 Antimicrob. Agents Chemother. doi:0./aac.0- Copyright 0, American Society for Microbiology. All Rights Reserved. Involvement of efflux pumps in
More informationPrevalence and molecular epidemiology of plasmidmediated fosfomycin resistance genes among blood and urinary Escherichia coli isolates
Journal of Medical Microbiology (2013), 62, 1707 1713 DOI 10.1099/jmm.0.062653-0 Prevalence and molecular epidemiology of plasmidmediated fosfomycin resistance genes among blood and urinary Escherichia
More informationTransfer of Herb-Resistance Plasmid From Escherichia coli to Staphylococcus aureus Residing in the Human Urinary Tract
Jundishapur J Microbiol. 2014 March; 7(3): e15056. Published online 2014 March 1. DOI: 10.5812/jjm.15056 Research Article Transfer of Herb-Resistance Plasmid From Escherichia coli to Staphylococcus aureus
More informationSerotype epidemiology and multidrug resistance patterns of Salmonella enterica infecting humans in Italy
DOI 10.1186/s13099-016-0110-8 Gut Pathogens RESEARCH Serotype epidemiology and multidrug resistance patterns of Salmonella enterica infecting humans in Italy Ilaria Frasson 1, Sabrina Bettanello 2, Ettore
More informationHo, PL; Yeung, MK; Lo, WU; Tse, H; Li, Z; Lai, ELY; Chow, KH; To, KK; Yam, WC
Title Author(s) Predominance of phk01-like incompatibility group FII plasmids encoding CTX-M-14 among extended-spectrum beta-lactamaseproducing Escherichia coli in Hong Kong, 1996-2008 Ho, PL; Yeung, MK;
More information